前收盘价格 | 0.395 |
收盘价格 | 0.395 |
平均成交量 (3个月) | 61,432 |
市值 | 147,694,464 |
市盈率 (P/E TTM) | 19.75 |
预期市盈率 (P/E Forward) | 18.80 |
价格/销量 (P/S) | 2.89 |
股市价格/股市净资产 (P/B) | 1.90 |
52周波幅 |
营业毛利率 | 16.97% |
营业利益率 (TTM) | 17.53% |
稀释每股收益 (EPS TTM) | 0.020 |
季度收入增长率 (YOY) | -0.40% |
季度盈利增长率 (YOY) | 20.30% |
总债务/股东权益 (D/E MRQ) | 0.50% |
流动比率 (MRQ) | 10.68 |
营业现金流 (OCF TTM) | 10.96 M |
杠杆自由现金流 (LFCF TTM) | -1.68 M |
资产报酬率 (ROA TTM) | 7.22% |
股东权益报酬率 (ROE TTM) | 11.85% |
市场趋势
短期 | 中期 | ||
行业 | Medical Devices (MY) | 混合的 | 混合的 |
Medical Devices (全球的) | 看跌 | 混合的 | |
股票 | UMC | 看跌 | 看跌 |
AIStockmoo 评分
分析师共识 | -0.5 |
内部交易活动 | 0.0 |
价格波动 | 0.5 |
技术平均移动指标 | 3.5 |
技术振荡指标 | -0.5 |
平均 | 0.60 |
Umedic Group Bhd is principally involved in the marketing and distribution of various branded medical devices and consumables as well as the provision of after-sales service for all products. The company is also involved in developing, manufacturing, and marketing of medical consumables. It has two reportable segments: marketing and distribution, which includes marketing and distribution of medical devices and the provision of after-sales service; the manufacturing segment includes developing, manufacturing, and marketing of medical devices. The company generates the majority of its revenue from the marketing and distribution segment. The company has customers in Asia Pacific, Americas, Europe, Middle East, Africa, and Oceania geographically. |
|
部门 | Healthcare |
行业 | Medical Devices |
投资方式 | Small Growth |
内部持股比例 | 73.21% |
机构持股比例 | 5.16% |
52周波幅 | ||
中 | 0.450 (13.92%) | |
总计 | 1 购买 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
PHILLIP CAPITAL | 06 Jun 2025 | 0.450 (13.92%) | 购买 | 0.395 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合